Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
American Journal of Clinical Oncology|December 9, 2008
Safety of adjuvant endocrine therapy in postmenopausal women with breast cancerHaifaa Abdulhaq, Charles GeyerSeminars in Oncology|October 19, 2004
Future options with trastuzumab for primary systemic and adjuvant therapyJosé Baselga, Luca Gianni, Charles Geyer, et al.Breast Cancer (Tokyo, Japan)|April 3, 2023
Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trialHideko Yamauchi, Masakazu Toi, Shin Takayama, et al.Cancer|November 27, 2004
Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinomaEdwin R Fisher, Stewart Anderson, Scott Dean, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast CancerChee Khoon Lee, Lucy Davies, Val J Gebski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
Clinical benefit of lapatinib-based therapy in patients with human epidermal growth factor receptor 2-positive breast tumors coexpressing the truncated p95HER2 receptorMaurizio Scaltriti, Sarat Chandarlapaty, Ludmila Prudkin, et al.Pageof 1